![Michael Jung](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Jung
Fundador en
Enlibrium, Inc.
.
Perfil
Michael Jung is the founder of Aragon Pharmaceuticals, Inc. (founded in 2009) and Seragon Pharmaceuticals, Inc. (founded in 2013).
He is also the founder of Enlibrium, Inc. Dr. Jung's current job is as a Professor at the University of California, Berkeley.
Cargos activos de Michael Jung
| Empresas | Cargo | Inicio |
|---|---|---|
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 07/04/2010 |
Enlibrium, Inc.
 Enlibrium, Inc. Medical/Nursing ServicesHealth Services Provides medical services | Fundador | - |
Antiguos cargos conocidos de Michael Jung.
| Empresas | Cargo | Fin |
|---|---|---|
Seragon Pharmaceuticals, Inc.
 Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer | Fundador | - |
Aragon Pharmaceuticals, Inc.
 Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Fundador | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
100
+
Relaciones de 1er grado
4
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aragon Pharmaceuticals, Inc.
Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Seragon Pharmaceuticals, Inc.
Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer | Health Technology |
Enlibrium, Inc.
Enlibrium, Inc. Medical/Nursing ServicesHealth Services Provides medical services | Health Services |
- Bolsa de valores
- Insiders
- Michael Jung
